The implications of the Supreme Court's decision on abortion for patients.

Published Date: 26 Apr 2023

Many women may be wondering what this means for them in light of the Supreme Court's decision on Friday regarding a crucial medication used in medical abortions.

Read Full News

Latest News

His Research on Pregnant Opioid Users Was Celebrated. Experts Found Major Flaws.

Some clinics still use approaches described in Craig Towers' research

Study Offers Reassurance on Inhaled Corticosteroid Use for Asthma in Pregnancy

— Asthma has been linked with adverse outcomes in both mothers and their offspring

Latest Breakthroughs in Antibody-Drug Conjugates for Endometrial Cancer: Insights From Recent Oncology Meetings

Latest Breakthroughs in Antibody-Drug Conjugates for Endometrial Cancer: Insights From Recent Oncology Meetings

Optimizing Treatment Persistence and Patient Outcomes Through Evidence-Based ADC-Associated Adverse Event Management by APPs on the Frontlines of Care

Optimizing Treatment Persistence and Patient Outcomes Through Evidence-Based ADC-Associated Adverse Event Management by APPs on the Frontlines of Care

Integrating Biomarker-Driven First-Line Maintenance Therapies in Advanced Ovarian Cancer

Integrating Biomarker-Driven First-Line Maintenance Therapies in Advanced Ovarian Cancer

Ascent to Evidence-Based ADC Integration: Real-World Strategies to Shape the Destiny of mBC Care

Ascent to Evidence-Based ADC Integration: Real-World Strategies to Shape the Destiny of mBC Care

Todays Updates

Milvexian Fails to Reduce CV Events After ACS

Patients in the phase 3 LIBREXIA ACS trial showed no reduction in cardiovascular events after acute coronary syndrome.

Atorvastatin Cuts Major CV Events by 30% in Older Adults in STAREE

Statin use for primary cardiovascular prevention in adults aged 70 years or older is supported by data from STAREE, although treatment did not prolong disability-free survival.

Phase 3 Eplontersen Trial Results Disappoint

Despite a major reduction in transthyretin amyloid deposits, eplontersen, a drug that reduces TTR production, did not reduce events associated with TTR amyloidosis in a phase 3 trial.

Todays Updates

Milvexian Fails to Reduce CV Events After ACS

Patients in the phase 3 LIBREXIA ACS trial showed no reduction in cardiovascular events after acute coronary syndrome.

Atorvastatin Cuts Major CV Events by 30% in Older Adults in STAREE

Statin use for primary cardiovascular prevention in adults aged 70 years or older is supported by data from STAREE, although treatment did not prolong disability-free survival.

Phase 3 Eplontersen Trial Results Disappoint

Despite a major reduction in transthyretin amyloid deposits, eplontersen, a drug that reduces TTR production, did not reduce events associated with TTR amyloidosis in a phase 3 trial.

Latest News

Some clinics still use approaches described in Craig Towers' research

— Asthma has been linked with adverse outcomes in both mothers and their offspring

Latest Breakthroughs in Antibody-Drug Conjugates for Endometrial Cancer: Insights From Recent Oncology Meetings

Optimizing Treatment Persistence and Patient Outcomes Through Evidence-Based ADC-Associated Adverse Event Management by APPs on the Frontlines of Care

Integrating Biomarker-Driven First-Line Maintenance Therapies in Advanced Ovarian Cancer

Ascent to Evidence-Based ADC Integration: Real-World Strategies to Shape the Destiny of mBC Care

News All Time

Experts Establish Pillars of Care for Older Adults With HIV

ART iniitiation, managing comorbidities addressed for aging patients

In Lindsay Clancy's Tragedy, I Recognize Something Painfully Familiar

A better model of care is urgently needed for postpartum mental health

Lindsay Clancy's Diary Chronicled Desperation and 'Brain Fog' Before She Killed Kids

"I want help. I want to be well," her attorney read from one journal entry

A Week After Shaving, She Developed Rare Flesh-Eating Disease

Fournier's gangrene followed a perineal shave and application of cream from an alternative healer

Despite Progress in TNBC, More Biomarkers Are Needed to Improve Outcomes

"PD-L1 is clinically useful but imperfect," expert says

Woman Says She Was Wrongly Diagnosed With Cancer, Had Surgery Due to Labeling Error

Atlanta-area patient filed lawsuit against the medical center

Residential Context Matters in Ovarian Cancer Survival

That's especially true for Black women

Debate on Use of SSRIs in Pregnancy Shifting, Experts Say

Researchers push for a focus on shared structured decision-making processes

Infants Possibly Exposed to HIV via Breast Milk Donated Over Social Media

Potentially exposed babies tracked down by investigators all tested negative

The Doctors Who 'Don't See Pregnant Patients'

Neither pregnancy nor abortion are siloed

Threat Monitoring, Legal Resources: How Hospitals Adapted to Abortion Bans

Institutional standards necessary to give physicians clarity, says researcher

This Fetus Had a Parasitic Twin in an Unusual Location

Extremely rare palatal fetus-in-fetu proved challenging for medical team

Her Vagina Burned Every Time She Ate Spicy Food

Case report details pain caused when capsaicin seeps past hardened fecal stones in fistula

ACOG Strengthens Support for Fallopian Tube Removal to Prevent Ovarian Cancer

Bilateral salpingectomy reduces risk by as much as 78%; consider during nongynecologic surgery

Lindsay Clancy's Defense Rests After Postpartum Psychosis Testimony

Closing arguments expected next week

Ousting RFK Jr. Among the Priorities for This Doctor Running for Senate

— South Carolina pediatrician also calls for a public option and to end extreme abortion bans

Recommended News For You

Researchers identify potential new therapeutic targets for treating T-cell lymphoma and natural killer cell tumors.

In a randomized trial, the kinder, gentler regimen for classical Hodgkin wins out.

Novel Psychedelic Promising on Resistant Depression

Blinatumomab Plus Chemotherapy New Standard for Children With B-Cell ALL

Junk Food & Prostate Cancer; 'Office' Star's Stage IV Diagnosis; New Cancer Cluster?

Is Lenalidomide Resistance in Myeloma Reversible with JAK Inhibition?

New imaging guidelines for head and neck cancers, a step toward practice change

Recommended Articles For You

How AI, Multi-Omics, and Real-World Evidence are Redefining Oncology Research and Shaping Cancer Care? 

Hypogammaglobulinemia: A Comprehensive Guide for Patients and Caregivers 

Paving the Path to Precision: A Review of TAR-200 in the Evolving Bladder Cancer Landscape 

Neonatal Hematopoietic Transition and Blood Cell Maturation 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Independent Risk Factors for "Deaths of Despair" Found.

2.

New imaging probe helps track prostate cancer and possibly treat it before resistance develops

3.

Proton Therapy Fails to Beat IMRT in Prostate Cancer

4.

Infection Burden High With Myeloma T-Cell Therapies

5.

PPI, Antibiotics May Curb Durvalumab Efficacy in NSCLC

1.

Genomic Control of Erythropoietic Stem Cell Renewal

2.

Case-Based Learning on Unexpected Cytopenia Patterns Following Advanced Therapies

3.

Subchorionic Hematoma: Causes, Symptoms, and Treatment 

4.

Clonal Hematopoiesis as a Mechanism of Age-Related Disease

5.

Transformative Insights in Oncology in Daily Practice

1.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

2.

International Cancer Conference

3.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

4.

Asian Symposium on Advancement in Hematology and Oncology

5.

Asian Symposium on Advancement in Hematology and Oncology

1.

Innovations in Hematology

2.

Case-Based Learning: Oncology

3.

EGFR Mutation Positive Non-Small Cell Lung Cancer- Case Discussion & Conclusion

4.

An Eagles View - Evidence-based Discussion on Iron Deficiency Anemia- The Conclusion

5.

Key Takeaways from The CROWN Trial For ALK + NSCLC Patients with CNS Diseases


Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot